A third major coronavirus vaccine candidate has revealed promising results in late-stage trials.
The final efficacy analysis of its late-stage trial suggest Pfizer and BioNtech's vaccine is safe and effective at preventing COVID-19.
Japan was scheduled to host the Olympic Games in the summer of 2020, but the coronavirus pandemic forced officials to postpone the competition until 2021.
This comes a week after Pfizer announced similar results, providing hope that the world may soon have multiple vaccines that work effectively.
Planning to attend an event but unsure of the COVID-19 risk, and if you should go at all? There's an evidence-based interactive webtool that can help.
SpaceX CEO Elon Musk has announced that he has received mixed results from tests meant to diagnose infections of the novel coronavirus.
Both COVID-19 cases and hospitalizations are rising rapidly and exponentially, shattering records set in the spring.
This comes on the the tail of Pfizer's announcement that its experimental coronavirus vaccine may be more than 90% effective in preventing an infection.
Researchers have uncovered a mysterious gene in the genetic code of the coronavirus SARS-CoV-2 – a segment virtually hidden from view in the virus's genome, and largely overlooked until now.